Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-EN Version v13-EN
Language English English
Date Updated 2024-04-04 2024-01-23
Drug Identification Number 02327902 02327902
Brand name SANDOZ CANDESARTAN PLUS SANDOZ CANDESARTAN PLUS
Common or Proper name CANDESARTAN PLUS CANDESARTAN PLUS
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 16MG 12.5MG 16MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30TAB UD 30TAB UD
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-24 2023-07-24
Estimated end date 2024-07-26 2024-03-22
Actual end date 2024-04-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments